MAZE
Maze Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.41 / 10
Outperform
Analyst sentiment is strongly bullish: 60% Strong Buy, 40% Buy, with weighted rating 6.91. Fund‑flow score 7.9 denotes good inflows across most size segments, though small‑cap flow is slightly negative. Overall money and analyst confidence support a positive outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
60%
Buy
40%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-18
InstitutionTruist Securities
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of MAZE?
- MAZE holds a Bullish analyst rating, with 60% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.41/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
